Selective and high affinity labeling of neuronal and recombinant nociceptin receptors with the hexapeptide radioprobe [3H]Ac-RYYRIK-ol

作者: Engin Bojnik , Judit Farkas , Anna Magyar , Csaba Tömböly , Ümit Güçlü

DOI: 10.1016/J.NEUINT.2009.04.014

关键词: Nociceptin receptorLigand binding assayChinese hamster ovary cellStereochemistryAffinity labelingBinding siteLigandReceptorPeptideChemistry

摘要: Abstract The synthetic hexapeptide Ac-Arg-Tyr-Tyr-Arg-Ile-Lys-ol (Ac-RYYRIK-ol) represents a highly potent and selective partial agonist ligand for the nociceptin/orphanin FQ (N/OFQ) peptide receptor (nociceptin receptor, NOPr). Ac-RYYRIK-ol has been labeled with tritium yielding [ 3 H]Ac-RYYRIK-ol exceptionally high specific radioactivity of 94 Ci/mmol. radioprobe is chemically stable even at 24 °C in ethanol solution least 4 days. No significant decomposition H]ligand occurred under condition binding experiments indicating fine enzymatic stability peptide. Radioreceptor studies were conducted using native neuronal NOPr preparation rat brain membrane fractions recombinant human nociceptin ( h NOPr) preparations from cultured Chinese Hamster Ovary (CHO) cells stably expressing NOPr. Specific compound was reversible, saturable affinity. cross-reaction opioid receptors observed suggesting superior selectivity ligand. Monophasic isotherm curves obtained radioligand saturation homologous displacement indicated presence single sites both preparations. Average densities recognition 237 749 fmol/mg protein transfected cells, respectively. Equilibrium affinity values K d s) determined by three independent way providing identical results. In membranes s 0.3–1.3 nM found depending upon assay type. competition performed on NOP-CHO cell almost same affinities measured either i 2.8 nM) or H](Leu 14 )nociceptin (2.3 nM). A number ligands screened heterologous displayed rank order profile being consistent fairly good H]Ac-RYYRIK-ol. Taken together, molar activity, improved chemical biological capability labeling make this novel available further exploring biochemical pharmacology receptor-ligand interaction NOP receptor.

参考文章(61)
Catherine Mollereau, Marc Parmentier, Pierre Mailleux, Jean-Luc Butour, Christiane Moisand, Pascale Chalon, Daniel Caput, Gilbert Vassart, Jean-Claude Meunier, ORL1, a novel member of the opioid receptor family: Cloning, functional expression and localization FEBS Letters. ,vol. 341, pp. 33- 38 ,(1994) , 10.1016/0014-5793(94)80235-1
G. Carra', G. Calo', B. Spagnolo, R. Guerrini, M. Arduin, E. Marzola, C. Trapella, D. Regoli, S. Salvadori, Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2. Journal of Peptide Research. ,vol. 66, pp. 39- 47 ,(2008) , 10.1111/J.1399-3011.2005.00272.X
Paola F. Zaratin, Giuseppe Petrone, Massimo Sbacchi, Martine Garnier, Claudia Fossati, Paola Petrillo, Silvio Ronzoni, Giuseppe A. M. Giardina, Mark A. Scheideler, Modification of nociception and morphine tolerance by the selective opiate receptor-like orphan receptor antagonist (-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol (SB-612111). Journal of Pharmacology and Experimental Therapeutics. ,vol. 308, pp. 454- 461 ,(2004) , 10.1124/JPET.103.055848
Hartmut Berger, Raffaella Bigoni, Erika Albrecht, Regina M Richter, Eberhard Krause, Michael Bienert, Girolamo Calo’, The nociceptin/orphanin FQ receptor ligand acetyl-RYYRIK-amide exhibits antagonistic and agonistic properties Peptides. ,vol. 21, pp. 1131- 1139 ,(2000) , 10.1016/S0196-9781(00)00251-5
Özge Gündüz, Anna Rizzi, Anna Baldisserotto, Remo Guerrini, Barbara Spagnolo, Elaine C Gavioli, László Kocsis, Anna Magyar, Sándor Benyhe, Anna Borsodi, Girolamo Calò, None, In vitro and in vivo pharmacological characterization of the nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-ol. European Journal of Pharmacology. ,vol. 539, pp. 39- 48 ,(2006) , 10.1016/J.EJPHAR.2006.03.075
Mahmoud Al-Khrasani, György Orosz, László Kocsis, Viktor Farkas, Anna Magyar, Imre Lengyel, Sándor Benyhe, Anna Borsodi, András Z Rónai, Receptor constants for endomorphin-1 and endomorphin-1-ol indicate differences in efficacy and receptor occupancy European Journal of Pharmacology. ,vol. 421, pp. 61- 67 ,(2001) , 10.1016/S0014-2999(01)01014-7
Yukihiro Noda, Takayoshi Mamiya, Toshitaka Nabeshima, Miyuki Nishi, Masaya Higashioka, Hiroshi Takeshima, Loss of Antinociception Induced by Naloxone Benzoylhydrazone in Nociceptin Receptor-Knockout Mice Journal of Biological Chemistry. ,vol. 273, pp. 18047- 18051 ,(1998) , 10.1074/JBC.273.29.18047
Jose-Luis Montiel, Fabrice Cornille, Bernard P. Roques, Florence Noble, Nociceptin/Orphanin FQ Metabolism: Role of Aminopeptidase and Endopeptidase 24.15 Journal of Neurochemistry. ,vol. 68, pp. 354- 361 ,(2002) , 10.1046/J.1471-4159.1997.68010354.X
Jim Yu, Brian T. Chait, Lawrence Toll, Mary Jeanne Kreek, Nociceptin in vitro biotransformation in human blood Peptides. ,vol. 17, pp. 873- 876 ,(1996) , 10.1016/0196-9781(96)00079-4